Filtered By:
Condition: Atrial Fibrillation
Procedure: Electrocardiogram

This page shows you your search results in order of relevance. This is page number 16.

Order by Relevance | Date

Total 721 results found since Jan 2013.

From cryptogenic to ESUS: Toward precision medicine?
Rev Neurol (Paris). 2022 May 18:S0035-3787(22)00592-6. doi: 10.1016/j.neurol.2022.01.016. Online ahead of print.ABSTRACTCryptogenic infarctions are infarctions without a defined cause, despite a complete work-up. They differ from infarctions of undetermined causes, which may involve overlapping causes or an incomplete investigation. It is also different from uncommon heritable and non-heritable causes. The term embolic stroke of undetermined source (ESUS) proposed in 2014 is defined as a non-lacunar brain infarct without proximal arterial stenosis or cardioembolic sources. The major advantage of this definition compared to...
Source: Revue Neurologique - May 21, 2022 Category: Neurology Authors: S Timsit Source Type: research

Atrial cardiomyopathy: from cell to bedside
AbstractAtrial cardiomyopathy refers to structural and electrical remodelling of the atria, which can lead to impaired mechanical function. While historical studies have implicated atrial fibrillation as the leading cause of cardioembolic stroke, atrial cardiomyopathy may be an important, underestimated contributor. To date, the relationship between atrial cardiomyopathy, atrial fibrillation, and cardioembolic stroke remains obscure. This review summarizes the pathogenesis of atrial cardiomyopathy, with a special focus on neurohormonal and inflammatory mechanisms, as well as the role of adipose tissue, especially epicardia...
Source: ESC Heart Failure - August 3, 2022 Category: Cardiology Authors: Mengmeng Li, Yuye Ning, Gary Tse, Ardan M. Saguner, Meng Wei, John D. Day, Guogang Luo, Guoliang Li Tags: Review Source Type: research

Cost‐effectiveness of early detection of atrial fibrillation via remote control of implanted devices
ConclusionRC potentially provides a risk reduction for stroke because it allows an early detection of new‐onset AF. Moreover, it is also a cost‐saving means of follow‐up.
Source: Journal of Evaluation in Clinical Practice - April 1, 2014 Category: Journals (General) Authors: Giulia Lorenzoni, Franco Folino, Nicola Soriani, Sabino Iliceto, Dario Gregori Tags: Original Article Source Type: research

Rationale and design of the Apixaban for the reduction of thrombo-embolism in patients with Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
Publication date: Available online 24 April 2017 Source:American Heart Journal Author(s): Renato D. Lopes, Marco Alings, Stuart J. Connolly, Heather Beresh, Christopher B. Granger, Juan Benezet Mazuecos, Giuseppe Boriani, Jens C. Nielsen, David Conen, Stefan H. Hohnloser, Georges H. Mairesse, Philippe Mabo, A. John Camm, Jeffrey S. Healey Device-detected subclinical atrial fibrillation (AF) refers to infrequent, short-lasting, asymptomatic AF that is detected only with long-term continuous monitoring. Subclinical AF is common and associated with an increased risk of stroke; however, the risk of stroke with subclinical AF ...
Source: American Heart Journal - April 24, 2017 Category: Cardiology Source Type: research

Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice.
CONCLUSIONS: It was determined that improved detection and diagnosis of AF, combined with appropriate anticoagulation strategies, will be crucial for improving stroke prevention and reducing its associated social and economic costs. PMID: 29034749 [PubMed - in process]
Source: European Journal of General Practice - October 18, 2017 Category: Primary Care Tags: Eur J Gen Pract Source Type: research

Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial
ConclusionsAmong patients ≥55 years of age with a recent cryptogenic stroke or TIA, 30-day smartphone ECG recording significantly improved the detection of AF when compared with the standard repeat 24-h Holter monitoring.
Source: Europace - March 30, 2021 Category: Cardiology Source Type: research

Atrial fibrillation: from detection to treatment. Role of the family physician, cardiologist and other specialists. New models of clinical management.
Abstract The prevalence of atrial fibrillation (AF) in adults in Spain is estimated to be 4.4% of the population aged 40 years or more, corresponding to a mean of 30 to 40 patients per family physician. The importance of this common arrhythmia lies, above all, in its close association with stroke and other systemic embolisms, among other possible complications. Diagnosis of AF is based on electrocardiographic recording and can consequently be made by the family physician, who should make an overall assessment of the patient's health, including risk factors, comorbidity and type of AF and evaluate embolic and hemor...
Source: Atencion Primaria - April 1, 2013 Category: Primary Care Authors: Sánchez SD, Lobos Bejarano JM, Gonzalez-Juanatey JR Tags: Aten Primaria Source Type: research

Atrial fibrillation and cognitive decline: A longitudinal cohort study
Conclusions: In the absence of clinical stroke, people with incident atrial fibrillation are likely to reach thresholds of cognitive impairment or dementia at earlier ages than people with no history of atrial fibrillation.
Source: Neurology - July 8, 2013 Category: Neurology Authors: Thacker, E. L., McKnight, B., Psaty, B. M., Longstreth, W. T., Sitlani, C. M., Dublin, S., Arnold, A. M., Fitzpatrick, A. L., Gottesman, R. F., Heckbert, S. R. Tags: Cardiac; see Cerebrovascular Disease/Cardiac, Cognitive aging, Cohort studies, Risk factors in epidemiology ARTICLE Source Type: research

Predictors of Anticoagulant Treatment in Patients With Nonvalvular Atrial Fibrillation: Results From Atrial Fibrillation in Turkey: Epidemiologic Registry
In this study, we demonstrated that stroke history, persistent/permanent AF, hypertension, DM, and left atrial diameter were positive predictors, whereas advanced age and heart failure were negative predictors of oral anticoagulant use in patients with nonvalvular AF.
Source: Clinical and Applied Thrombosis/Hemostasis - February 2, 2015 Category: Hematology Authors: Kaya, H., Ertaş, F., Koroğlu, B., Vatan, B., Cağlıyan, C. E., Gedik, S., Yeter, E., Aydin, M., Akil, M. A., Soydinc, M. S., Ozhan, H., Ulgen, M. S., for the AFTER Investigators Tags: Original Articles Source Type: research

Prevalence of atrial fibrillation in an urban population in India: the Nagpur pilot study
Conclusions The prevalence of AF was low compared with other regions of the world and stroke prophylaxis was underused. A larger study is needed to confirm these findings. This study demonstrates that larger evaluations would be feasible using the community-based techniques employed here.
Source: Heart Asia - April 17, 2016 Category: Cardiology Authors: Saggu, D. K., Sundar, G., Nair, S. G., Bhargava, V. C., Lalukota, K., Chennapragada, S., Narasimhan, C., Chugh, S. S. Tags: Original research Source Type: research

Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry
The prevalence of interatrial block (IAB) is high in the elderly, particularly in those with heart disease. Despite this high prevalence—and the association of IAB with the risk of atrial fibrillation (AF), stroke, and cognitive decline—little information exists about the prognosis of older patients with IAB. P‐wave duration and morphology are associated with risk of developing AF, stroke, and cognitive decline in elderly patients with structural heart disease. The aim of the Interatrial Block and Yearly Events (BAYES) registry is to assess the impact of IAB on the risk of AF and stroke during 3 years of follow‐up....
Source: Clinical Cardiology - September 30, 2016 Category: Cardiology Authors: Manuel Mart ínez‐Sellés, Adrian Baranchuk, Roberto Elosua, Antonio Bayés Luna Tags: Trial Designs Source Type: research

Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring
Conclusions The prevalence of PAF found in a population referred for continuous 24-hour electrocardiographic monitoring for diverse reasons was 2.5% and the overall AF/AFL prevalence was 12.4%. PAF was more prevalent in younger patients. Patients with PAF showed a significantly lower prevalence of hypertension and significantly higher rates of stroke. Systematically detecting patients with PAF is a major public health concern, since early diagnosis is essential to identify candidates for oral anticoagulation and catheter ablation, which is frequently curative when applied at this stage.
Source: Revista Portuguesa de Cardiologia - July 20, 2017 Category: Cardiology Source Type: research

Subclinical Atrial Fibrillation in Older Patients.
Conclusions -SCAF is frequently detected by continuous electrocardiographic monitoring in older patients without prior history of AF who are attending outpatient cardiology and neurology clinics. Its clinical significance is unclear. Clinical Trial Registration -URL: www.ClinicalTrials.gov Unique Identifier: NCT01694394. PMID: 28778946 [PubMed - as supplied by publisher]
Source: Circulation - August 4, 2017 Category: Cardiology Authors: Healey JS, Alings M, Ha AC, Leong-Sit P, Birnie DH, de Graaf JJ, Freericks M, Verma A, Wang J, Leong D, Dokainish H, Philippon F, Barake W, McIntyre WF, Simek KD, Hill MD, Mehta SR, Carlson M, Smeele F, Pandey AS, Connolly SJ, ASSERT-2 Investigators Tags: Circulation Source Type: research

The SAFIRA study: A reflection on the prevalence and treatment patterns of atrial fibrillation and cardiovascular risk factors in 7500 elderly subjects
Conclusions This study shows the high prevalence of AF in the elderly population, as well as suboptimal rates of diagnosis, anticoagulation and effective control of cardiovascular risk factors.
Source: Revista Portuguesa de Cardiologia - April 24, 2018 Category: Cardiology Source Type: research